Literature DB >> 8476070

Pulmonary surfactant protein A stimulates chemotaxis of alveolar macrophage.

J R Wright1, D C Youmans.   

Abstract

Pulmonary surfactant modulates several functions of alveolar macrophages including phagocytosis, killing, and chemotaxis. We hypothesized that the reported stimulatory effect of surfactant on macrophage migration was mediated by one of the surfactant proteins, SP-A. We found that macrophage migration was stimulated by SP-A in a concentration-dependent manner. A concentration of 105 micrograms SP-A/ml enhanced migration approximately 10-fold. Heat treatment or reduction and alkylation of SP-A reduced its stimulatory effect. A checker-board analysis showed that SP-A stimulated migration primarily by enhancing chemotaxis (directed movement) rather than chemokinesis (random movement). The interaction of SP-A with macrophages may be mediated at least partly by the collagen-like domain of SP-A. We speculate that SP-A may play a multifunctional role in regulating pulmonary immune response by stimulating multiple macrophage functions.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8476070     DOI: 10.1152/ajplung.1993.264.4.L338

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  37 in total

1.  Impact of sex and ozone exposure on the course of pneumonia in wild type and SP-A (-/-) mice.

Authors:  Anatoly N Mikerov; Sanmei Hu; Faryal Durrani; Xiaozhuang Gan; Guirong Wang; Todd M Umstead; David S Phelps; Joanna Floros
Journal:  Microb Pathog       Date:  2012-01-20       Impact factor: 3.738

2.  Identification of the surfactant protein A receptor 210 as the unconventional myosin 18A.

Authors:  Ching-Hui Yang; Jacek Szeliga; Jeremy Jordan; Shawn Faske; Zvjezdana Sever-Chroneos; Bre Dorsett; Robert E Christian; Robert E Settlage; Jeffrey Shabanowitz; Donald F Hunt; Jeffrey A Whitsett; Zissis C Chroneos
Journal:  J Biol Chem       Date:  2005-08-08       Impact factor: 5.157

3.  Surfactant protein A2 (SP-A2) variants expressed in CHO cells stimulate phagocytosis of Pseudomonas aeruginosa more than do SP-A1 variants.

Authors:  Anatoly N Mikerov; Guirong Wang; Todd M Umstead; Mario Zacharatos; Neal J Thomas; David S Phelps; Joanna Floros
Journal:  Infect Immun       Date:  2007-01-12       Impact factor: 3.441

4.  Surfactant protein A stimulates release of neutrophil chemotactic factors by alveolar type II pneumocytes.

Authors:  Mitchell J Kresch; Mitchell Block; Mohammed R Karim; Li Zhu; Naveed Hussain; Roger S Thrall; Ramadan I Sha'afi
Journal:  Lung       Date:  2010-05-16       Impact factor: 2.584

5.  Regulation of protein phosphorylation and pathogen phagocytosis by surfactant protein A.

Authors:  T L Schagat; M J Tino; J R Wright
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441

6.  The role of nitric oxide in lung innate immunity: modulation by surfactant protein-A.

Authors:  Philip O'Reilly; Judy M Hickman-Davis; Philip McArdle; K Randall Young; Sadis Matalon
Journal:  Mol Cell Biochem       Date:  2002 May-Jun       Impact factor: 3.396

7.  Interleukin-4 enhances pulmonary clearance of Pseudomonas aeruginosa.

Authors:  S Jain-Vora; A M LeVine; Z Chroneos; G F Ross; W M Hull; J A Whitsett
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

8.  Impact of ozone exposure on the phagocytic activity of human surfactant protein A (SP-A) and SP-A variants.

Authors:  Anatoly N Mikerov; Todd M Umstead; Xiaozhuang Gan; Weixiong Huang; Xiaoxuan Guo; Guirong Wang; David S Phelps; Joanna Floros
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2007-11-02       Impact factor: 5.464

9.  Binding of host collectins to the pathogenic yeast Cryptococcus neoformans: human surfactant protein D acts as an agglutinin for acapsular yeast cells.

Authors:  S Schelenz; R Malhotra; R B Sim; U Holmskov; G J Bancroft
Journal:  Infect Immun       Date:  1995-09       Impact factor: 3.441

10.  Surfactant protein A influences reepithelialization in an alveolocapillary model system.

Authors:  Coen H M P Willems; Luc J I Zimmermann; Renate M R Langen; Maria J A van den Bosch; Nico Kloosterboer; Boris W Kramer; J Freek van Iwaarden
Journal:  Lung       Date:  2012-10-13       Impact factor: 2.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.